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Introduction 
The sensory epithelia of the avian inner ear have the capacity to regenerate after acoustic 
trauma or ototoxic injury (Cotanche, 1987; Cruz et al., 1987).  Such regeneration is primarily the 
result of renewed supporting cell proliferation (Tsue et al., 1994; Warchol, 2007).  The human 
inner ear lacks the ability to regenerate hair cells, and thus is permanently damaged by 
ototoxicity, aging, acoustic trauma, and other epithelial insults.  Understanding the cellular 
signaling pathways involved in supporting cell proliferation is fundamental to developing 
treatments. This study examines the contribution of mitogen-activated protein kinases (MAPKs) 
toward the initiation of regenerative proliferation in chick utricular epithelia. 
 
Mechanisms of hair cell regeneration 
Proliferation of supporting cells gives rise to new hair cells in both the auditory and 
vestibular organs (reviewed by Matsui et al., 2005; Stone & Cotanche, 2007). Following hair cell 
injury, supporting cell proliferation rates increase and the daughter cells produced through 
mitosis differentiate into replacement hair cells or supporting cells.  Auditory nerve fibers then 
connect to the new hair cells, leading to nearly complete functional recovery.  
Hair cell regeneration may also occur through direct transdifferentiation of supporting 
cells.  Roberson et al. (2004) reported that the earliest replacement hair cells (which are evident 
4-6 days after gentamicin injection) are created via direct transdifferentiation.  However, 
proliferation soon predominates as the primary means of regeneration.  By ten days following 
gentamicin treatment, most regenerated hair cells are derived from supporting cell proliferation. 
Proliferation has an advantage over direct transdifferentiation in that the ratio of hair cells 
to supporting cells is maintained.  While transdifferentiation produces more immediate recovery, 
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one supporting cell is lost with the creation of every new hair cell.  With proliferation, daughter 
cells may become hair cells or supporting cells, allowing the sensory epithelium to maintain its 
balance of hair cells and supporting cells.   
Limited regeneration through supporting cell proliferation has also been reported in 
mammalian utricles following aminoglycoside ototoxicity (Warchol et al., 1993). While this 
finding provides hope for regeneration as a therapeutic target, more research is needed to 
determine the mechanisms by which regenerative proliferation occurs.  Currently, little is known 
about the cell cycle control factors related to supporting cell proliferation. 
 
Overview of mitogen-activated protein kinases 
Mitogen-activated protein kinases (MAPKs) are a family of enzymes that phosphorylate 
proteins, initiating cell-signaling cascades involved in cell-cycle entry. MAPKs are activated by 
upstream kinase cascades located in the cytoplasm.  These typically involve three protein kinases 
organized by a scaffold protein.  Each kinase in the cascade phosphorylates the next, culminating 
in activation of the MAPK.  Once activated, the MAPK may phosphorylate various proteins and 
transcription factors, including those involved with cell-cycle control (Darnell, 2003).   
There are three avian and mammalian MAPK pathways: extracellular signal-regulated 
kinase (ERK), c-Jun NH2-terminal kinase (JNK), and p38.  Each pathway contributes to specific 
cellular responses.  The particular response elicited by pathway activation is dependent on 
several variables, including the intensity and duration of stimulation, the specific MAPK isoform 
activated, the scaffold protein utilized, the pathway location within the cell, possible interaction 
between MAPK pathways, and activity of other molecules within the cell (reviewed by Krishna 
& Narang, 2008). 
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The extracellular signal-regulated kinase (ERK) subfamily is activated by a variety of 
stimuli, including growth factors, hormones, and neurotransmitters.  The ERK cascade is 
involved in proliferation, cell cycle control (particularly G1-S phase transition), and 
differentiation (reviewed in Rubinfeld & Seger, 2005).  Transient ERK activation promotes 
proliferation, while sustained activation induces differentiation (reviewed in Chambard et al., 
2007).   
The c-Jun NH2-terminal kinase (JNK) subfamily is activated in response to cellular 
stress, reactive oxygen species, cytokines, and growth factors.  Its primary role is in stress-
induced apoptosis, though it has also been implicated in proliferation, differentiation, and cell 
survival (reviewed in Vlahopoulos & Zoumpourlis, 2004).  Ten JNK isoforms have been 
identified. 
Six isoforms of p38 have been identified.  Like JNK, the p38 subfamily is involved with 
inflammatory responses and cell death.  Activation occurs in response to cytokines and 
extracellular stress.  p38 plays a role in apoptosis, inflammation, cytokine production and 
differentiation (reviewed in Ono & Han, 2000).  This pathway has also been associated with cell 
cycle arrest at the G1-S phase transition (reviewed in Zhang & Liu, 2002).   
 
Purpose of the present study 
While it is widely understood that the MAPK pathways play a role in cellular 
proliferation, there has not been a comprehensive comparison of the respective contribution of 
each kinase towards the regulation of proliferation in the avian inner ear.  The aim of the study is 
to identify the relative activation of the three MAP kinase pathways and quantify changes in 
proliferation after blocking each pathway.  The resulting data will contribute to growing 
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knowledge about the proliferative pathways in chick sensory epithelia.  As the mechanisms of 
this process are discovered, researchers will be closer to developing treatment strategies for 
pathologies in the human inner ear. 
 
 
MATERIALS AND METHODS 
 
Preparation of epithelial cultures 
 Utricles were removed from chicks at 14-21 days post-hatch and incubated in 
thermolysin.  The sensory epithelia were removed using a 30-gauge needle, then transferred to 
fibronectin- or laminin-coated culture wells containing Medium-199 with Earle’s salts and 10% 
fetal bovine serum.  The epithelia were cut into 10-12 small pieces.  The cultures were incubated 
at 37°C for three days, rinsed with Medium 199, and incubated an additional three days.   
 
ERK, JNK, and p38 Pathway Quantification 
The number of cells with activated forms of each kinase was assessed using 
immunocytochemistry.  Data for each MAP kinase was obtained from eight separate cultures. 
Cultures were briefly rinsed with Medium-199, fixed for fifteen minutes in 4% 
paraformadehyde, and rinsed with phosphate buffered saline (PBS) five times over fifteen 
minutes.  Prior to immunolabeling, cultures were treated for two hours with blocking solution 
that consisted of PBS with 0.2% Triton X-100 and 5% normal horse serum.  Cultured supporting 
cells were labeled with rabbit anti-ERK (1:250, Cell Signaling Technologies, Beverly, MA, 
USA), rabbit anti-phospho-c-Jun (1:100, Cell Signaling Technologies), or rabbit anti-p38 (1:500, 
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Cell Signaling Technologies) antibodies in 2% normal horse serum and 1 mL 0.2% Triton-X (in 
PBS) were applied, and cultures were incubated overnight at 4°C. 
The next day, cultures were rinsed five times over fifteen minutes with PBS.  Secondary 
antibodies, consisting of cy3 anti-rabbit (1:500, GE Healthcare, Buckinghamshire, UK), 
Phalloidin (1:40, Invitrogen, Eugene, OR, USA), and DAPI (1:500, Sigma, St. Louis, MO, USA) 
in 0.2% Triton-X (in PBS) were applied over two hours at room temperature.  Cultures were 
rinsed five times over fifteen minutes with PBS, and then coverslipped with 9:1 glycerol/PBS 
solution.   
 
BrdU Immunocytochemistry 
BrdU immunocytochemistry was used to examine the effects of inhibiting each MAP 
kinase pathway on supporting cell proliferation.  In each experiment, four wells of dissociated 
chick utricular epithelia were treated with a small molecule inhibitor, and four wells acted as a 
control group.  U0126 (10 μm, Calbiochem, La Jolla, CA, USA) was used to block ERK, 
SB203580 (20 μm, Calbiochem) to block p38, and SP600125 (10 μm, Calbiochem) to block 
JNK.   
Cultures were incubated at 37°C for twenty hours. Each well was then treated with 3 
μl/ml bromodeoxyuridine (BrdU, Sigma) to label cells in the S-phase of the cell cycle.  Cultures 
were then incubated at 37°C for four hours.  This procedure was repeated with three sets of 
cultures for each inhibitor, so that a total of twelve treated wells and twelve controls were 
obtained for each condition.   
Cultures were rinsed with Medium-199 and fixed in 4% paraformadehyde for 15 
minutes.  Cultures were rinsed with PBS five times over fifteen minutes and treated with 100 μL 
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of 1N HCl for fifteen minutes to denature DNA.  Cultures were then rinsed with PBS five times 
over fifteen minutes and treated for two hours with blocking solution containing 5% normal 
horse serum in 0.2% Triton-X (in PBS).  Primary antibodies, consisting of 1:50 Anti-BrdU (BD 
Biosciences, San Jose, CA, USA) and 2% normal horse serum in 0.2% Triton-X (in PBS) were 
applied, and cultures were incubated overnight at 4°C. 
The next day, cultures were rinsed five times over fifteen minutes with PBS and treated 
with secondary antibody (1:500 Alexa 488 anti-mouse (Invitrogen) and 1:500 DAPI in 0.2% 
Triton-X (in PBS)) over two hours at room temperature.  Cultures were rinsed five times over 
fifteen minutes with PBS, then coverslipped with 9:1 glycerol/PBS solution.   
 
Imaging 
Images were obtained using a Nikon Eclipse TE2000-S immunofluorescence microscope 
equipped with a Q Imaging Retiga 1300 camera.  Four to six images were obtained for each well 
using QCapture v2.8.1 software.  Labeled cells were quantified using Image-Pro Plus v2.5.1.29 
software.  After quantification of the labeled cells in each image, the proliferation index for each 
treatment was calculated by dividing the number of BrdU-labeled cells by the number of DAPI-
labeled cells.  Statistical significance was assessed using a 2-tailed T-test, and was compared 
across treatment conditions.   
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RESULTS 
Pathway Quantification
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Immunofluorescent microscopy revealed varying levels of 
cell density throughout each well.  Images were obtained from 
regions bordering high-density zones, with attempt to minimize 
the amount of overlapping cells and maintain uniform cell density 
for each image.    
Graph 1: Levels of expression of ERK, 
p-c-Jun, and p38. 
Quantification of cells that were immunolabeled for 
activated members of the MAPK pathway revealed high levels of 
expression of ERK activation (98.83%, Figure 1A).  Phospho-c-Jun was expressed in 5.66% of 
cells (Figure 1B), and p38 expression was rare (0.34%, Figure 1C).   
Fig 1A: ERK expression. Nuclei 
labeled with DAPI (blue), cytoplasm 
expressing ERK labeled with cy3 
(red). 
Fig 1B: p-c-Jun expression.  Nuclei 
labeled with DAPI (blue), nuclei 
expressing p-c-Jun labeled with cy3 
(red). 
Fig 1C: p38 expression. Nuclei 
labeled with DAPI (blue), nuclei 
expressing p38 labeled with cy3 
(red). 
 
Inhibiting these pathways had varying effects upon proliferation.  Cultures treated with 
U0126 to block ERK contained 8.78 ± 5.25 BrdU+ cells/100,000 μm2 (Figure 2A), while control 
cultures contained 21.66 ± 10.78 BrdU+ cells/100,000 μm2 (Figure 2B).  This treatment resulted 
in a statistically significant reduction in proliferation indices from 6.15% to 2.73% (p<0.001) 
(Graph 2).  
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Cultures treated with SP600125 to block JNK contained 19.2 ± 8.98 BrdU+ cells/100,000 
μm2 (Figure 3B), compared to 26.97 ± 11.31 BrdU+ cells/100,000 μm2 in control wells (Figure 
3A).  Blocking JNK had a statistically significant effect on proliferation, reducing the percentage 
of BrdU-labeled cells from 11% to 7.66% (p<0.001) (Graph 3).   
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There was no statistically significant difference in proliferation between cultures treated 
with SB203580 to block p38 and control cultures (Graph 4).  Control cultures contained 17.87 ± 
8.52 BrdU+ cells/100,000 μm2 (Figure 4A), while treated cultures contained 20.72 ± 10.26 
BrdU+ cells/100,000 μm2 (Figure 4B). 
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Proliferation of chick utricular epithelial cultures in control and MAPK-inhibited conditions.  DAPI labeling (blue); 
BrdU labeling (red).  Fig 2A: control culture, Fig 2B: ERK-inhibited.  Fig 3A: control culture, Fig 3B: JNK-
inhibited.  Fig 4A: control culture, Fig 4B: p38-inhibited. Graphs 2, 3, and 4: Proliferation indices for control and 
treated cultures in ERK-, JNK-, and p38-inhibited conditions, respectively. 
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DISCUSSION 
 Hair cell regeneration in the inner ear occurs primarily through proliferation of 
supporting cells.  MAP kinases are known to be involved in cellular proliferation, but their role 
in the inner ear is not yet understood.  The purpose of this study was to examine the contribution 
of each MAP kinase pathway toward proliferation in chick utricular epithelia.  The results 
obtained suggest ERK and JNK are key mediators in regulating this proliferation.  Future 
research should further clarify the role of these kinases, as they have potential to become 
therapeutic targets for mammalian hair cell regeneration. 
 
ERK 
High levels of ERK expression were found in cultures of dissociated chick utricular 
epithelia.  Blocking ERK with U0126 significantly reduced proliferation.  This result supports 
findings by Witte et al. (2002), which reported that treating cultures with U0126 significantly 
reduced proliferation of chick supporting cells.  Other ERK inhibitors, PD98059 and apigenin, 
also reduced S-phase entry in these cultures (Witte et al., 2002).   
ERK inhibitors may also decrease proliferation of supporting cells in the avian basilar 
papilla (Bell and Oberholtzer, in press).  In this study, researchers used forskolin to induce 
proliferation of auditory supporting cells in cultures treated with ERK inhibitors and control 
cultures.  ERK-inhibited cultures had significantly fewer BrdU-labeled cells.  Thus ERK may be 
important for proliferation in both the auditory and vestibular organs. 
3A 
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JNK 
Phospho-c-Jun was expressed less frequently than ERK, and blocking JNK also reduced 
proliferation.  JNK has been found to play a role in proliferation of other cells types, including 
human breast cancer cells (Mingo-Sion et al., 2004), rat hepatocytes (Schwabe et al., 2003), KB-
3 human carcinoma cells (Du et al., 2004), and murine and human B-lymphoma cells (Gururajan 
et al., 2005).  In each of these studies, inhibition of JNK with SP600125 reduced proliferation. 
Studies of JNK in the inner ear have primarily focused on its role in apoptosis.  Inhibition 
of JNK has been demonstrated to reduce hair cell death and hearing loss resulting from 
ototoxicity (Bodmer et al., 2002; Ylikoski et al., 2002; Sugahara et al., 2006), acoustic trauma 
(Wang et al., 2003; Coleman et al. 2007), and electrode insertion trauma (Eshraghi et al., 2007).  
JNK may be involved in both proliferation and apoptosis in the inner ear.  Its role may depend on 
a variety of factors, including the time course of activation and cross-talk with other pathways. 
The duration of MAPK pathway stimulation influences the cellular response (reviewed in 
Krishna & Narang, 2008).  Within the JNK pathway, the length of activation may influence 
whether proliferation or apoptosis results.  In a study of T-cells, Chen et al. (1996) found that 
transient JNK activation promoted proliferation, while prolonged activation resulted in increased 
apoptosis.  It is possible that similar effects occur in supporting cells. 
Cross-talk between JNK and ERK has been demonstrated to be responsible for 
proliferation of VEGF-stimulated bovine aortic endothelial cells (Pedram et al., 1998).  This 
study demonstrated that, following VEGF stimulation, ERK activates upstream kinases in the 
JNK pathway, leading to activation of JNK.  While ERK is necessary for JNK activation, it is 
JNK that is ultimately responsible for the majority of proliferation of these cells (Pedram et al., 
1998).  Further study is needed of MAPK pathway interaction in the inner ear. 
13 
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p38 
Expression of p38 was comparatively low, and blocking p38 did not have a significant 
effect on proliferation.  Although this suggests p38 does not have a primary role in avian 
supporting cell proliferation, this MAPK may still be a target for therapies aiming to ameliorate 
hair cell damage.  A recent study by Tabuchi et al. (in press) implicates p38 in mammalian 
cochlear outer hair cell fate following acoustic overexposure.  Acoustic overexposure activated 
p38 in murine cochlear hair cells, and inhibiting p38 with SB203580 diminished ABR threshold 
shifts following this insult.  Similarly, Wei et al. (2005) found that gentamicin induced an 
upregulation of p38 in murine outer hair cells, and p38-inhibition with SB203580 protected hair 
cells from ototoxicity.  Thus, while p38 may not be involved in supporting cell proliferation, 
further study of this kinase is warranted. 
 
Conclusion 
Together, these results suggest that ERK and JNK play key roles in the proliferation of 
chick utricular epithelia, while p38 alone does not regulate proliferation.  Additional research 
involving multi-kinase inhibition is needed to establish whether these kinases together have 
additive or synergistic effects.  Cross-talk between pathways should be examined, as well as the 
effects of duration of pathway activation.  Future research should examine similarities and 
differences in the roles of the MAPK pathways in the chick basilar papilla.  Finally, MAPK 
activation should be studied in the mammalian inner ear to determine whether differences in 
these pathways may be responsible for reduced proliferation.  A better understanding of these 
kinases may lead to therapies for hair cell damage in the human ear. 
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